Key result
Higher circulating hepatocyte growth factor levels after acute myocardial infarction correlated with left ventricular remodelling and death or heart failure rehospitalization (P=0.0006 at 1 month).
Why the study?
Are circulating levels of hepatocyte growth factor (HGF) associated with left ventricular remodelling and clinical outcomes in patients after acute MI?
Cohort (n=246)
Yes
Are circulating levels of hepatocyte growth factor (HGF) associated with left ventricular remodelling and clinical outcomes in patients after acute MI?
Circulating HGF levels correlate with markers of LV remodelling and are associated with adverse clinical outcomes such as death or rehospitalization for heart failure after acute MI.
No takes yet. Share an insight, caveat, or question.
HGF may identify higher-risk post-MI patients; leaves open incremental prognostic value and therapeutic implications.
Lamblin et al. (2011) conducted a cohort in Acute Myocardial Infarction (n=246). Circulating hepatocyte growth factor (HGF) was evaluated on Left ventricular remodelling and death or rehospitalization for heart failure. Higher circulating hepatocyte growth factor levels after acute myocardial infarction correlated with left ventricular remodelling and death or heart failure rehospitalization (P=0.0006 at 1 month).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: